Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-31

Clinical Trial Update: Status Migrainosus - Differentiating Between Responders and Non-responders [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update exploring predictors of response among responders and non-responders in status migrainosus, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hartford HealthCare | Conditions: Migraine | Phase 1, Phase 2 | Status: UNKNOWN